These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 26384381

  • 1. Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.
    Hernández C, Bogdanov P, Corraliza L, García-Ramírez M, Solà-Adell C, Arranz JA, Arroba AI, Valverde AM, Simó R.
    Diabetes; 2016 Jan; 65(1):172-87. PubMed ID: 26384381
    [Abstract] [Full Text] [Related]

  • 2. Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.
    Hernández C, Bogdanov P, Solà-Adell C, Sampedro J, Valeri M, Genís X, Simó-Servat O, García-Ramírez M, Simó R.
    Diabetologia; 2017 Nov; 60(11):2285-2298. PubMed ID: 28779212
    [Abstract] [Full Text] [Related]

  • 3. Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.
    Shu X, Zhang Y, Li M, Huang X, Yang Y, Zeng J, Zhao Y, Wang X, Zhang W, Ying Y.
    Neuropharmacology; 2019 Jul 15; 153():1-12. PubMed ID: 31015047
    [Abstract] [Full Text] [Related]

  • 4. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis.
    Fan Y, Liu K, Wang Q, Ruan Y, Zhang Y, Ye W.
    Mol Vis; 2014 Jul 15; 20():1557-68. PubMed ID: 25489228
    [Abstract] [Full Text] [Related]

  • 5. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
    Zhang Y, Wang Q, Zhang J, Lei X, Xu GT, Ye W.
    Graefes Arch Clin Exp Ophthalmol; 2009 May 15; 247(5):699-706. PubMed ID: 19084986
    [Abstract] [Full Text] [Related]

  • 6. Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
    Solà-Adell C, Bogdanov P, Hernández C, Sampedro J, Valeri M, Garcia-Ramirez M, Pasquali C, Simó R.
    Curr Eye Res; 2017 Sep 15; 42(9):1273-1286. PubMed ID: 28574750
    [Abstract] [Full Text] [Related]

  • 7. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
    Zhang Y, Zhang J, Wang Q, Lei X, Chu Q, Xu GT, Ye W.
    Invest Ophthalmol Vis Sci; 2011 Jan 05; 52(1):278-85. PubMed ID: 20688733
    [Abstract] [Full Text] [Related]

  • 8. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
    Li Y, Bader M, Tamargo I, Rubovitch V, Tweedie D, Pick CG, Greig NH.
    J Neurochem; 2015 Dec 05; 135(6):1203-1217. PubMed ID: 25982185
    [Abstract] [Full Text] [Related]

  • 9. The Anti-Inflammatory Effects of Glucagon-Like Peptide Receptor Agonist Lixisenatide on the Retinal Nuclear and Nerve Fiber Layers in an Animal Model of Early Type 2 Diabetes.
    Chung YW, Lee JH, Lee JY, Ju HH, Lee YJ, Jee DH, Ko SH, A Choi J.
    Am J Pathol; 2020 May 05; 190(5):1080-1094. PubMed ID: 32354571
    [Abstract] [Full Text] [Related]

  • 10. GLP-1 Treatment Improves Diabetic Retinopathy by Alleviating Autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway.
    Cai X, Li J, Wang M, She M, Tang Y, Li J, Li H, Hui H.
    Int J Med Sci; 2017 May 05; 14(12):1203-1212. PubMed ID: 29104476
    [Abstract] [Full Text] [Related]

  • 11. The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.
    Baggio LL, Ussher JR, McLean BA, Cao X, Kabir MG, Mulvihill EE, Mighiu AS, Zhang H, Ludwig A, Seeley RJ, Heximer SP, Drucker DJ.
    Mol Metab; 2017 Nov 05; 6(11):1339-1349. PubMed ID: 29107282
    [Abstract] [Full Text] [Related]

  • 12. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
    Gumuslu E, Cine N, Ertan M, Mutlu O, Komsuoglu Celikyurt I, Ulak G.
    Fundam Clin Pharmacol; 2018 Apr 05; 32(2):174-180. PubMed ID: 29091313
    [Abstract] [Full Text] [Related]

  • 13. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
    Wallner M, Kolesnik E, Ablasser K, Khafaga M, Wakula P, Ljubojevic S, Thon-Gutschi EM, Sourij H, Kapl M, Edmunds NJ, Kuzmiski JB, Griffith DA, Knez I, Pieske B, von Lewinski D.
    J Mol Cell Cardiol; 2015 Dec 05; 89(Pt B):365-75. PubMed ID: 26432951
    [Abstract] [Full Text] [Related]

  • 14. The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice.
    Li PC, Liu LF, Jou MJ, Wang HK.
    BMC Neurosci; 2016 Jun 13; 17(1):37. PubMed ID: 27296974
    [Abstract] [Full Text] [Related]

  • 15. Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.
    Jia Y, Gong N, Li TF, Zhu B, Wang YX.
    Pharmacol Res; 2015 Dec 13; 102():276-85. PubMed ID: 26546042
    [Abstract] [Full Text] [Related]

  • 16. The potential benefits of glucagon-like peptide-1 receptor agonists for diabetic retinopathy.
    Pang B, Zhou H, Kuang H.
    Peptides; 2018 Feb 13; 100():123-126. PubMed ID: 28807775
    [Abstract] [Full Text] [Related]

  • 17. An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke.
    Zhang H, Liu Y, Guan S, Qu D, Wang L, Wang X, Li X, Zhou S, Zhou Y, Wang N, Meng J, Ma X.
    PLoS One; 2016 Feb 13; 11(2):e0148827. PubMed ID: 26863436
    [Abstract] [Full Text] [Related]

  • 18. Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes Study.
    Gaborit B, Julla JB, Besbes S, Proust M, Vincentelli C, Alos B, Ancel P, Alzaid F, Garcia R, Mailly P, Sabatier F, Righini M, Gascon P, Matonti F, Houssays M, Goumidi L, Vignaud L, Guillonneau X, Erginay A, Dupas B, Marie-Louise J, Autié M, Vidal-Trecan T, Riveline JP, Venteclef N, Massin P, Muller L, Dutour A, Gautier JF, Germain S.
    J Clin Endocrinol Metab; 2020 Apr 01; 105(4):. PubMed ID: 31589290
    [Abstract] [Full Text] [Related]

  • 19. Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study.
    Morano S, Romagnoli E, Filardi T, Nieddu L, Mandosi E, Fallarino M, Turinese I, Dagostino MP, Lenzi A, Carnevale V.
    Acta Diabetol; 2015 Aug 01; 52(4):727-32. PubMed ID: 25577244
    [Abstract] [Full Text] [Related]

  • 20. [Effects of GLP-1 receptor agonists on carbohydrate metabolism control].
    Fernández-García JC, Colomo N, Tinahones FJ.
    Med Clin (Barc); 2014 Aug 01; 143 Suppl 2():18-22. PubMed ID: 25326839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.